Autoimmune Pancreatitis with Extreme Elevation of DUPAN-2

An 80-year-old woman was admitted to our hospital with complaints of jaundice and liver dysfunction. She was found to have a high titer of serum IgG4, positive rheumatoid factor and marked elevation of DUPAN-2 (11,148 U/ml). Computed tomography showed swelling of the pancreas, and endoscopic retrogr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 2007, Vol.46(7), pp.377-381
Hauptverfasser: Mishima, Shiho, Mizuta, Yohei, Yamao, Takuji, Yamakawa, Masaki, Akazawa, Yuko, Mishima, Ryosuke, Ohba, Kazuo, Masuda, Jun-ich, Ohnita, Ken, Isomoto, Hajime, Shikuwa, Saburo, Omagari, Katsuhisa, Kohno, Shigeru
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 381
container_issue 7
container_start_page 377
container_title Internal Medicine
container_volume 46
creator Mishima, Shiho
Mizuta, Yohei
Yamao, Takuji
Yamakawa, Masaki
Akazawa, Yuko
Mishima, Ryosuke
Ohba, Kazuo
Masuda, Jun-ich
Ohnita, Ken
Isomoto, Hajime
Shikuwa, Saburo
Omagari, Katsuhisa
Kohno, Shigeru
description An 80-year-old woman was admitted to our hospital with complaints of jaundice and liver dysfunction. She was found to have a high titer of serum IgG4, positive rheumatoid factor and marked elevation of DUPAN-2 (11,148 U/ml). Computed tomography showed swelling of the pancreas, and endoscopic retrograde cholangiopancreatography revealed diffuse irregular narrowing of the main pancreatic duct, which are typical findings of autoimmune pancreatitis. There was no evidence of malignancy. Administration of 30 mg/day of prednisolone was started. Computed tomography showed significant regression in the size of the pancreas, and the stenosis of the main pancreatic duct was improved on ERCP. The serum level of DUPAN-2 was also markedly decreased after the treatment.
doi_str_mv 10.2169/internalmedicine.46.6184
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_907165270</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>907165270</sourcerecordid><originalsourceid>FETCH-LOGICAL-c598t-45ab6ffdbe6b0e0d275284b2c15f0cc1524b040754501bc09af5f03e6a9be5713</originalsourceid><addsrcrecordid>eNp9kEtLAzEUhYMotj7-gsxKV1OTTB6TZdH6gKJd6Dpk0js2Mg9NMj7-vSktCiJuzoV7vnsuHIQygieUCHXuugi-M00LS2ddBxMmJoKUbAeNScFULmnBd9EYK1LmNMkIHYTwjHFRSkX30YhIhpXAZIzUdIi9a9uhg2xhOuvBRBddyN5dXGWzj-ihhWzWwFva913W19nl42J6l9MjtFebJsDxdh6ix6vZw8VNPr-_vr2YznPLVRlzxk0l6npZgagw4CWVnJasopbwGtuklFWYYckZx6SyWJk6GQUIoyrgkhSH6GyT--L71wFC1K0LFprGdNAPQSssieBU4kSe_ksmhClJ1pHlBrS-D8FDrV-8a43_1ATrdcH6d8GaCb0uOJ2ebH8MVTJ_DreNJmC-AZ5DNE_wDRgfnW3gz2S5kULKb8yujNfQFV8n1Zen</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70349711</pqid></control><display><type>article</type><title>Autoimmune Pancreatitis with Extreme Elevation of DUPAN-2</title><source>MEDLINE</source><source>J-STAGE</source><creator>Mishima, Shiho ; Mizuta, Yohei ; Yamao, Takuji ; Yamakawa, Masaki ; Akazawa, Yuko ; Mishima, Ryosuke ; Ohba, Kazuo ; Masuda, Jun-ich ; Ohnita, Ken ; Isomoto, Hajime ; Shikuwa, Saburo ; Omagari, Katsuhisa ; Kohno, Shigeru</creator><creatorcontrib>Mishima, Shiho ; Mizuta, Yohei ; Yamao, Takuji ; Yamakawa, Masaki ; Akazawa, Yuko ; Mishima, Ryosuke ; Ohba, Kazuo ; Masuda, Jun-ich ; Ohnita, Ken ; Isomoto, Hajime ; Shikuwa, Saburo ; Omagari, Katsuhisa ; Kohno, Shigeru</creatorcontrib><description>An 80-year-old woman was admitted to our hospital with complaints of jaundice and liver dysfunction. She was found to have a high titer of serum IgG4, positive rheumatoid factor and marked elevation of DUPAN-2 (11,148 U/ml). Computed tomography showed swelling of the pancreas, and endoscopic retrograde cholangiopancreatography revealed diffuse irregular narrowing of the main pancreatic duct, which are typical findings of autoimmune pancreatitis. There was no evidence of malignancy. Administration of 30 mg/day of prednisolone was started. Computed tomography showed significant regression in the size of the pancreas, and the stenosis of the main pancreatic duct was improved on ERCP. The serum level of DUPAN-2 was also markedly decreased after the treatment.</description><identifier>ISSN: 0918-2918</identifier><identifier>ISSN: 1349-7235</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.46.6184</identifier><identifier>PMID: 17409601</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject>Acute Disease ; Adrenal Cortex Hormones - therapeutic use ; Aged, 80 and over ; Antigens, Neoplasm - blood ; Autoimmune Diseases - blood ; Autoimmune Diseases - diagnosis ; Autoimmune Diseases - drug therapy ; autoimmune pancreatitis ; Biomarkers - blood ; Cholangiopancreatography, Endoscopic Retrograde - methods ; Diagnosis, Differential ; DUPAN-2 ; Female ; Humans ; IgG4 ; Pancreatic Function Tests ; Pancreatic Neoplasms - diagnosis ; Pancreatitis - blood ; Pancreatitis - diagnosis ; Pancreatitis - drug therapy ; Risk Assessment ; Severity of Illness Index ; steroid ; Tomography, X-Ray Computed ; Treatment Outcome</subject><ispartof>Internal Medicine, 2007, Vol.46(7), pp.377-381</ispartof><rights>2007 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c598t-45ab6ffdbe6b0e0d275284b2c15f0cc1524b040754501bc09af5f03e6a9be5713</citedby><cites>FETCH-LOGICAL-c598t-45ab6ffdbe6b0e0d275284b2c15f0cc1524b040754501bc09af5f03e6a9be5713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,1884,27926,27927</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17409601$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mishima, Shiho</creatorcontrib><creatorcontrib>Mizuta, Yohei</creatorcontrib><creatorcontrib>Yamao, Takuji</creatorcontrib><creatorcontrib>Yamakawa, Masaki</creatorcontrib><creatorcontrib>Akazawa, Yuko</creatorcontrib><creatorcontrib>Mishima, Ryosuke</creatorcontrib><creatorcontrib>Ohba, Kazuo</creatorcontrib><creatorcontrib>Masuda, Jun-ich</creatorcontrib><creatorcontrib>Ohnita, Ken</creatorcontrib><creatorcontrib>Isomoto, Hajime</creatorcontrib><creatorcontrib>Shikuwa, Saburo</creatorcontrib><creatorcontrib>Omagari, Katsuhisa</creatorcontrib><creatorcontrib>Kohno, Shigeru</creatorcontrib><title>Autoimmune Pancreatitis with Extreme Elevation of DUPAN-2</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>An 80-year-old woman was admitted to our hospital with complaints of jaundice and liver dysfunction. She was found to have a high titer of serum IgG4, positive rheumatoid factor and marked elevation of DUPAN-2 (11,148 U/ml). Computed tomography showed swelling of the pancreas, and endoscopic retrograde cholangiopancreatography revealed diffuse irregular narrowing of the main pancreatic duct, which are typical findings of autoimmune pancreatitis. There was no evidence of malignancy. Administration of 30 mg/day of prednisolone was started. Computed tomography showed significant regression in the size of the pancreas, and the stenosis of the main pancreatic duct was improved on ERCP. The serum level of DUPAN-2 was also markedly decreased after the treatment.</description><subject>Acute Disease</subject><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Aged, 80 and over</subject><subject>Antigens, Neoplasm - blood</subject><subject>Autoimmune Diseases - blood</subject><subject>Autoimmune Diseases - diagnosis</subject><subject>Autoimmune Diseases - drug therapy</subject><subject>autoimmune pancreatitis</subject><subject>Biomarkers - blood</subject><subject>Cholangiopancreatography, Endoscopic Retrograde - methods</subject><subject>Diagnosis, Differential</subject><subject>DUPAN-2</subject><subject>Female</subject><subject>Humans</subject><subject>IgG4</subject><subject>Pancreatic Function Tests</subject><subject>Pancreatic Neoplasms - diagnosis</subject><subject>Pancreatitis - blood</subject><subject>Pancreatitis - diagnosis</subject><subject>Pancreatitis - drug therapy</subject><subject>Risk Assessment</subject><subject>Severity of Illness Index</subject><subject>steroid</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><issn>0918-2918</issn><issn>1349-7235</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLAzEUhYMotj7-gsxKV1OTTB6TZdH6gKJd6Dpk0js2Mg9NMj7-vSktCiJuzoV7vnsuHIQygieUCHXuugi-M00LS2ddBxMmJoKUbAeNScFULmnBd9EYK1LmNMkIHYTwjHFRSkX30YhIhpXAZIzUdIi9a9uhg2xhOuvBRBddyN5dXGWzj-ihhWzWwFva913W19nl42J6l9MjtFebJsDxdh6ix6vZw8VNPr-_vr2YznPLVRlzxk0l6npZgagw4CWVnJasopbwGtuklFWYYckZx6SyWJk6GQUIoyrgkhSH6GyT--L71wFC1K0LFprGdNAPQSssieBU4kSe_ksmhClJ1pHlBrS-D8FDrV-8a43_1ATrdcH6d8GaCb0uOJ2ebH8MVTJ_DreNJmC-AZ5DNE_wDRgfnW3gz2S5kULKb8yujNfQFV8n1Zen</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Mishima, Shiho</creator><creator>Mizuta, Yohei</creator><creator>Yamao, Takuji</creator><creator>Yamakawa, Masaki</creator><creator>Akazawa, Yuko</creator><creator>Mishima, Ryosuke</creator><creator>Ohba, Kazuo</creator><creator>Masuda, Jun-ich</creator><creator>Ohnita, Ken</creator><creator>Isomoto, Hajime</creator><creator>Shikuwa, Saburo</creator><creator>Omagari, Katsuhisa</creator><creator>Kohno, Shigeru</creator><general>The Japanese Society of Internal Medicine</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20070101</creationdate><title>Autoimmune Pancreatitis with Extreme Elevation of DUPAN-2</title><author>Mishima, Shiho ; Mizuta, Yohei ; Yamao, Takuji ; Yamakawa, Masaki ; Akazawa, Yuko ; Mishima, Ryosuke ; Ohba, Kazuo ; Masuda, Jun-ich ; Ohnita, Ken ; Isomoto, Hajime ; Shikuwa, Saburo ; Omagari, Katsuhisa ; Kohno, Shigeru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c598t-45ab6ffdbe6b0e0d275284b2c15f0cc1524b040754501bc09af5f03e6a9be5713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Acute Disease</topic><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Aged, 80 and over</topic><topic>Antigens, Neoplasm - blood</topic><topic>Autoimmune Diseases - blood</topic><topic>Autoimmune Diseases - diagnosis</topic><topic>Autoimmune Diseases - drug therapy</topic><topic>autoimmune pancreatitis</topic><topic>Biomarkers - blood</topic><topic>Cholangiopancreatography, Endoscopic Retrograde - methods</topic><topic>Diagnosis, Differential</topic><topic>DUPAN-2</topic><topic>Female</topic><topic>Humans</topic><topic>IgG4</topic><topic>Pancreatic Function Tests</topic><topic>Pancreatic Neoplasms - diagnosis</topic><topic>Pancreatitis - blood</topic><topic>Pancreatitis - diagnosis</topic><topic>Pancreatitis - drug therapy</topic><topic>Risk Assessment</topic><topic>Severity of Illness Index</topic><topic>steroid</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mishima, Shiho</creatorcontrib><creatorcontrib>Mizuta, Yohei</creatorcontrib><creatorcontrib>Yamao, Takuji</creatorcontrib><creatorcontrib>Yamakawa, Masaki</creatorcontrib><creatorcontrib>Akazawa, Yuko</creatorcontrib><creatorcontrib>Mishima, Ryosuke</creatorcontrib><creatorcontrib>Ohba, Kazuo</creatorcontrib><creatorcontrib>Masuda, Jun-ich</creatorcontrib><creatorcontrib>Ohnita, Ken</creatorcontrib><creatorcontrib>Isomoto, Hajime</creatorcontrib><creatorcontrib>Shikuwa, Saburo</creatorcontrib><creatorcontrib>Omagari, Katsuhisa</creatorcontrib><creatorcontrib>Kohno, Shigeru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mishima, Shiho</au><au>Mizuta, Yohei</au><au>Yamao, Takuji</au><au>Yamakawa, Masaki</au><au>Akazawa, Yuko</au><au>Mishima, Ryosuke</au><au>Ohba, Kazuo</au><au>Masuda, Jun-ich</au><au>Ohnita, Ken</au><au>Isomoto, Hajime</au><au>Shikuwa, Saburo</au><au>Omagari, Katsuhisa</au><au>Kohno, Shigeru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Autoimmune Pancreatitis with Extreme Elevation of DUPAN-2</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>46</volume><issue>7</issue><spage>377</spage><epage>381</epage><pages>377-381</pages><issn>0918-2918</issn><issn>1349-7235</issn><eissn>1349-7235</eissn><abstract>An 80-year-old woman was admitted to our hospital with complaints of jaundice and liver dysfunction. She was found to have a high titer of serum IgG4, positive rheumatoid factor and marked elevation of DUPAN-2 (11,148 U/ml). Computed tomography showed swelling of the pancreas, and endoscopic retrograde cholangiopancreatography revealed diffuse irregular narrowing of the main pancreatic duct, which are typical findings of autoimmune pancreatitis. There was no evidence of malignancy. Administration of 30 mg/day of prednisolone was started. Computed tomography showed significant regression in the size of the pancreas, and the stenosis of the main pancreatic duct was improved on ERCP. The serum level of DUPAN-2 was also markedly decreased after the treatment.</abstract><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>17409601</pmid><doi>10.2169/internalmedicine.46.6184</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-2918
ispartof Internal Medicine, 2007, Vol.46(7), pp.377-381
issn 0918-2918
1349-7235
1349-7235
language eng
recordid cdi_proquest_miscellaneous_907165270
source MEDLINE; J-STAGE
subjects Acute Disease
Adrenal Cortex Hormones - therapeutic use
Aged, 80 and over
Antigens, Neoplasm - blood
Autoimmune Diseases - blood
Autoimmune Diseases - diagnosis
Autoimmune Diseases - drug therapy
autoimmune pancreatitis
Biomarkers - blood
Cholangiopancreatography, Endoscopic Retrograde - methods
Diagnosis, Differential
DUPAN-2
Female
Humans
IgG4
Pancreatic Function Tests
Pancreatic Neoplasms - diagnosis
Pancreatitis - blood
Pancreatitis - diagnosis
Pancreatitis - drug therapy
Risk Assessment
Severity of Illness Index
steroid
Tomography, X-Ray Computed
Treatment Outcome
title Autoimmune Pancreatitis with Extreme Elevation of DUPAN-2
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T19%3A26%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Autoimmune%20Pancreatitis%20with%20Extreme%20Elevation%20of%20DUPAN-2&rft.jtitle=Internal%20Medicine&rft.au=Mishima,%20Shiho&rft.date=2007-01-01&rft.volume=46&rft.issue=7&rft.spage=377&rft.epage=381&rft.pages=377-381&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.46.6184&rft_dat=%3Cproquest_cross%3E907165270%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70349711&rft_id=info:pmid/17409601&rfr_iscdi=true